Dr. Anke Michel Huisarts financials
A multi-period view of the public annual-account figures reported for Dr. Anke Michel Huisarts, with comparable measures and links to available source documents.
Company overviewRegistry number
0835640944
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Dr. Anke Michel Huisarts
2025 versus 2024
- Operating line
- €90,376
- EBITDA
- €89,251
- Total assets
- €501,648
- Equity
- €368,942
-25.9%
-26.2%
+12.3%
-13.2%
EBITDA margin +98.8% · Equity ratio +73.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €90,376 | €89,251 | €501,648 | €368,942 | - |
| 202431 Dec 2024 | €122,040 | €120,969 | €446,643 | €424,840 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.